KiwiNet Board Chairman
An early career in science, sales and management of technologically advanced organisations combined with later leadership and development roles provides a wide perspective on success in its many forms. Ngaio has a real passion for relationship management and her key strengths lie in relationships, strategic thinking and innovation.
Andrew trained as a Chemical and Process Engineer and then spent 12 years in Biotech and Pharmaceutical Industries in the UK. His experience spanned manufacturing, engineering, business development and R&D. He was a Director and part of the executive management team that executed a successful turnaround of a small, fully integrated, specialty pharmaceutical company (Allergy Therapeutics plc) and subsequent listing on the London Stock Exchange.
Since returning to New Zealand 10 years ago Andrew has been actively involved in early stage technology businesses as an investor, advisor and entrepreneur. He is a director and shareholder in; Lypanosys (A Phase 2 drug for Atopic Dermatitis); Kayasand (A company with novel technology for the manufacture of sand from quarry waste streams); APD (New Zealand’s leading plastic fabrication company); is a Venture partner in the GRC SinoGreen Fund; and is a Director and Chairman of the Investment Committee for KiwiNet, which invests Government PreSeed Accelerator Funding into transforming scientific discoveries emerging from research organisations into new business for New Zealand.
Founder and CEO - Mint Innovation
Will is CEO and co-founder of Mint Innovation and Director of the Health Research Council of New Zealand. He’s is an executive experienced in commercialising new technologies through securing IP, fund-raising and building high performance teams. Drawing on a wealth of experience in science and technology-based businesses, with a focus on securing value, technology commercialisation, intellectual property and corporate organization, Will strives to create value across a wide range of technology areas. Will’s specialties: include entrepreneurship, investment, clean energy, business and IP strategy, and sustainability.
Chief Executive Officer of Viclink Ltd
Prior to becoming CEO, Anne spent four years growing and developing the IP and Commercialisation team within Viclink as General Manager of Commercialisation, taking it from a team of one to a team of many, driving process and a significant increase in the numbers of disclosures. A physical scientist by training, Anne is passionate about bringing science, technology and society together.
Anne's career has focused largely on business development and science commercialisation activities for organisations such as Creative HQ (Wellington’s business incubator), the MacDiarmid Institute for Advanced Materials and Nanotechnology, and Izon Science Ltd, a nanotechnology start-up. She has also successfully run her own business providing marketing, business development and strategic consulting services for science and high-tech sectors.
Chief Executive Officer Plant and Food Research
David Hughes studied at Massey University, NZ, gaining both a BTech (Manufacturing) 1st Class Hons and a Postgraduate Diploma in Applied Statistics. Mr Hughes, as CEO, oversees all aspects of the organisation's operation and represents the Institute on a number of Boards and committees.
Mr Hughes joined Plant & Food Research in July 2009 as Group General Manager Commercial, and was appointed CEO in February 2018. He has a successful track record of business development and innovation within the food sector, including several high-profile roles within the dairy industry in New Zealand, Australia, USA, Japan and Bahrain.